| Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149) |
|---|
| 10/26/2005 | EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 10/20/2005 | WO2005097761A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 10/20/2005 | WO2005049561A3 Processes for preparing novel methylene blue derivative |
| 10/20/2005 | WO2005030794B1 Hemiasterlin derivatives and uses thereof |
| 10/20/2005 | WO2004112575A3 Gene amplification and overexpression in cancer |
| 10/20/2005 | US20050234050 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 10/20/2005 | CA2560966A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 10/19/2005 | EP1397170B1 Safety shield system for prefilled syringes |
| 10/19/2005 | CN1684682A Small organic molecules that increase the activity of gelatinase A in ocular cells |
| 10/19/2005 | CN1683349A 2-imino-tetrahydro-1, 3-benzothiazine derivative and its preparing method |
| 10/13/2005 | US20050227969 A piperidin-2-one, 1,3-oxazinan-2-one, or 1,3-thiazinan-2-one compound for treatment of glaucoma, mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts; 7-{(4S)-4-[(3R)-3-hydroxy-4-phenylbutyl]-2-oxo-1,3-oxazinan-3-yl}heptanoic acid; side effect reduction |
| 10/12/2005 | EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 10/12/2005 | CN1681768A Process for production of high-purity enamines |
| 10/11/2005 | US6953794 Monitoring treatment for nervous system didorders; obtain cell sample containing tau protein, incubate with modulator, monitor tau binding, adjustment in tau binding indicates modulators |
| 10/06/2005 | WO2005092872A1 Peptide deformylase inhibitors |
| 10/06/2005 | WO2005092392A2 Conjugated psychotropic drugs and uses thereof |
| 10/06/2005 | WO2005092099A1 Hiv integrase inhibitors |
| 10/06/2005 | US20050222217 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags |
| 10/06/2005 | US20050222142 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence |
| 10/06/2005 | US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance |
| 10/06/2005 | US20050220888 Controlled release compositions and methods for using same |
| 10/06/2005 | CA2560905A1 Conjugated psychotropic drugs and uses thereof |
| 10/06/2005 | CA2557785A1 Hiv integrase inhibitors |
| 10/05/2005 | CN1678592A 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers |
| 10/05/2005 | CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol |
| 09/29/2005 | US20050215549 TACE inhibitors |
| 09/29/2005 | US20050214875 Metal chelate containing compositions for use in chemiluminescent assays |
| 09/22/2005 | WO2005087754A1 Substituted morpholine and thiomorpholine derivatives |
| 09/21/2005 | CN1219515C In vivo stain compounds and methods of use to identify dysplastic tissue |
| 09/20/2005 | CA2285119C Retroviral protease inhibiting compounds |
| 09/15/2005 | WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 09/09/2005 | WO2005082882A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 09/09/2005 | WO2005082872A1 Benzothiazin-3-one compound and intermediate therefor |
| 09/09/2005 | CA2560664A1 Benzothiazin-3-one compound and intermediate therefor |
| 09/09/2005 | CA2554439A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 09/08/2005 | US20050197326 1,4-benzothiazin-3-ones that are optionally S-mono- or dioxygenated, quinoxazinones, quinolinones and benzapinones; peptide deformylase inhibitors, used for treating bacterial infections |
| 09/07/2005 | EP1569916A1 Substituted aralkyl derivatives |
| 09/07/2005 | EP1569904A1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 09/07/2005 | EP1165087B1 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 09/06/2005 | US6939988 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them |
| 08/31/2005 | EP1568697A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof |
| 08/31/2005 | EP1567494A1 Methods for preparing phenylalkyne derivatives |
| 08/31/2005 | EP1567488A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 08/31/2005 | CN1660839A Chemical compounds |
| 08/31/2005 | CN1216874C (Hetero) aryl-substituted heterocyclic enaminones, production thereof and use thereof as herbicides, acaricides and insectivides |
| 08/25/2005 | WO2005026208A3 Chimeric gabab receptor |
| 08/25/2005 | US20050187110 Novel herbicides |
| 08/23/2005 | US6933261 2,4,5-Trisubstituted phenylketoenols |
| 08/18/2005 | WO2005030794A3 Hemiasterlin derivatives and uses thereof |
| 08/17/2005 | EP1562925A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/16/2005 | US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis |
| 08/11/2005 | WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 08/11/2005 | US20050176969 Novel fused ring compounds, and their use as cationic photoinitiators |
| 08/10/2005 | EP1451166B1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 08/09/2005 | US6927216 Treatment of inflammatory disorders |
| 08/04/2005 | US20050171092 Chemical compounds |
| 08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
| 08/03/2005 | CN1213036C Novel amide derivatives |
| 07/28/2005 | US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides |
| 07/28/2005 | US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides |
| 07/27/2005 | CN1212166C Safety shield system for prefilled syringes |
| 07/26/2005 | US6921760 Psychotherapeutic agents. |
| 07/21/2005 | WO2003105811A8 Controlled release compositions and methods for using same |
| 07/20/2005 | EP1056717B1 Arylphenyl-substituted cyclic keto-enols |
| 07/14/2005 | WO2005063692A1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 07/14/2005 | US20050153456 Analysis of mass spectral data in the quiet zones |
| 07/13/2005 | EP1553077A1 Process for production of high-purity enamines |
| 07/13/2005 | EP1551817A2 Transient optical state change materials useful in copy-protected compact discs |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916806 Such as 2-(2-isopropylphenyl)imino-5,5-dimethyl-1,3-thiazine which has binding activity to the cannabinoid type-2 receptors |
| 07/12/2005 | US6916667 Metal chelate containing compositions for use in chemiluminescent assays |
| 07/06/2005 | CN1636005A Benzothiazinone and benzoxazinone compounds |
| 07/05/2005 | US6914059 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
| 06/30/2005 | US20050143576 Process for production of high-purity enamines |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/23/2005 | WO2005056536A1 Antidiabetic agents which exhibit activity against ppar |
| 06/23/2005 | WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases |
| 06/22/2005 | EP1544193A1 Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof |
| 06/22/2005 | EP1542687A1 Small organic molecules that increase the activity of gelatinase a in ocular cells |
| 06/22/2005 | CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/21/2005 | US6908937 Heterocyclic fluoroalkenyl thioethers (II) |
| 06/16/2005 | WO2005054871A2 Analysis of mass spectral data in the quiet zones |
| 06/16/2005 | WO2005054217A1 Developments in biologically active methylene blue derivatives (2) |
| 06/16/2005 | US20050131022 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer |
| 06/16/2005 | CA2547556A1 Developments in biologically active methylene blue derivatives (2) |
| 06/16/2005 | CA2542941A1 Analysis of mass spectral data in the quiet zones and label selection therefor |
| 06/15/2005 | EP1539176A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 06/15/2005 | EP1104412B1 Tace inhibitors |
| 06/15/2005 | CN1627970A Safety shield system for prefilled syringe |
| 06/15/2005 | CN1627961A Toluidine blue O drug substance and use thereof for in VIVO Staining and chemo therapeutic treatment of dysplastic tissues |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/09/2005 | WO2005051932A1 Arylheterocycle derivative and agricultural or horticulrual bactericide and insecticide |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124617 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |